Tempest Therapeutics, Inc. Other Accrued Liabilities, Current
Tempest Therapeutics, Inc. (TPST) had Other Accrued Liabilities, Current of $662.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $662.00K.
- 2026-03-31: Other Accrued Liabilities, Current $1.11M.
- 2025-12-31: Other Accrued Liabilities, Current $627.00K.
- 2025-09-30: Other Accrued Liabilities, Current $1.05M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $662.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.11M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $627.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.05M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $990.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.33M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.02M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.03M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $873.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $626.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $953.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.13M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $756.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.32M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.25M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $748.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.25M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $838.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $113.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $441.00K 10-K · filed 2022-03-29 | $350.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $346.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $565.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $752.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $852.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $306.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $366.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $560.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $512.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $913.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $581.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $678.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $169.00K 10-K · filed 2019-04-01 | $792.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | $1.54M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $3.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $2.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.16M 10-K · filed 2018-03-15 | $2.46M 10-K · filed 2017-03-02 |
| 2015-12-31 | $2.57M 10-K · filed 2017-03-02 | $2.24M 10-K · filed 2016-02-26 |
| 2014-12-31 | $712.00K 10-K · filed 2016-02-26 | |
| 2013-12-31 | $178.00K 10-K · filed 2015-03-16 | |
| 2012-12-31 | $178.00K 10-K · filed 2014-02-27 | $45.00K 10-K · filed 2013-02-25 |
| 2012-09-30 | $73.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $114.00K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $13.00K 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |